Q32 Bio Inc. Stock price

Equities

QTTB

US7469641051

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 09:54:43 2024-03-28 am EDT 5-day change 1st Jan Change
16.47 USD +1.86% Intraday chart for Q32 Bio Inc. -0.73% +47.75%
Dynamic Chart
Q32 Bio Inc.(NasdaqGM:QTTB) added to NASDAQ Composite Index CI
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from NASDAQ Composite Index CI
Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors CI
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction. CI
North American Morning Briefing : Markets on Hold -2- DJ
Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Neurogene Names Julie Jordan as Chief Medical Officer MT
Q32 Bio Inc. announced that it expects to receive $42 million in funding from a group of investors CI
Homology Medicines, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from S&P Global BMI Index CI
North American Morning Briefing : China Trouble -2- DJ
Homology Medicines, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
North American Morning Briefing : Wall Street Eyes -2- DJ
Baird Downgrades Homology Medicines to Neutral From Outperform, Adjusts Price Target to $1.50 From $9 MT
Homology Medicines, Inc. Approves Reduction in Workforce CI
More news

Latest transcript on Q32 Bio Inc.

1 week
15.07
Extreme 15.07
17.35
1 month
15.07
Extreme 15.07
17.35
Current year
15.07
Extreme 15.07
17.35
1 year
15.07
Extreme 15.07
17.35
3 years
15.07
Extreme 15.07
17.35
5 years
15.07
Extreme 15.07
17.35
10 years
15.07
Extreme 15.07
17.35
More quotes
  1. Stock
  2. Equities
  3. Stock Q32 Bio Inc. - Nasdaq